John A. Catanzaro

Chief Innovation Officer, Board Member, Founder
John A. Catanzaro
Chief Innovation Officer, Board Member, Founder
John Catanzaro received his Doctorate of Naturopathic Medicine from Bastyr University in 1995.

He has retired from clinical practice and was the former founder and CEO of the largest integrative cancer center in Seattle. He innovated patient-precision patient matched immuno-peptides and cell therapy to train defense cells to eradicate very advanced cancers considered incurable failing all conventional treatments with successful outcomes.

He also was affiliate/adjunct faculty for Bastyr University and taught integrative cancer outpatient medicine to medical students and resident physicians for 15 years. He served on Bastyr Institutional Review Board for 6 years. He was appointed by the Governor and served Washington Department of Health Quality Assurance Board for Naturopathic Medicine for five years as Co-Chair. He also served on the CDC Medical Board Cancer Commission representing Washington State for two years as a medical advisor on integrative cancer care. Dr. Catanzaro also was a former member of the American Association for Cancer Research (AACR).

Dr. Catanzaro's experience with NGS, proteomics, HLA immunomolecular applications, CRISPR technology functional laboratory technology, and clinical utility is a rare blend that has paved the way to advanced innovation.

Previous experience includes founder and cofounder of two genetic testing companies, namely HealthCoach7 and GeneSavvy. He was clinically active in integrative oncology for over 20 years and brings his knowledge and experience to architect precision based personalized therapeutics in healthcare.,